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Abstract
Objective: Specific phobia (SP) is characterized by irrational fear associated with avoidance of 
specific stimuli. In recent years, neuroimaging techniques have been used in an attempt to better 
understand the neurobiology of anxiety disorders. The objective of this study was to perform a 
systematic review of articles that used neuroimaging techniques to study SP. Method: A literature 
search was conducted through electronic databases, using the keywords: imaging, neuroimaging, 
PET, spectroscopy, functional magnetic resonance, structural magnetic resonance, SPECT, MRI, DTI, 
and tractography, combined with simple phobia and specific phobia. One-hundred fifteen articles 
were found, of which 38 were selected for the present review. From these, 24 used fMRI, 11 used 
PET, 1 used SPECT, 2 used structural MRI, and none used spectroscopy. Result: The search showed 
that studies in this area were published recently and that the neuroanatomic substrate of SP has 
not yet been consolidated. Conclusion: In spite of methodological differences among studies, 
results converge to a greater activation in the insula, anterior cingulate cortex, amygdala, and 
prefrontal and orbitofrontal cortex of patients exposed to phobia-related situations compared 
to controls. These findings support the hypotheses of the hyperactivation of a neuroanatomic 
structural network involved in SP. 
©2012 Elsevier Editora Ltda. 
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Neuroimagem do transtorno de fobia específica: uma revisão sistemática da 
literatura
Resumo
A Fobia Específica (SP do inglês) é caracterizada por medos irracionais associados à evitação 
de estímulos específicos. Nos últimos anos, técnicas de neuroimagem vêm sendo empregadas 
na tentativa de melhor compreender a neurobiologia dos transtornos de ansiedade. O objetivo 
do presente estudo é realizar uma revisão sistemática dos artigos que utilizaram neuroimagem 
para estudar a SP. A busca na literatura foi realizada por intermédio de indexadores eletrônicos, 
utilizando-se as palavras-chave: imaging, neuroimaging, PET, spectroscopy, functional magnetic 
ressonance, structural magnetic ressonance, SPECT, MRI, DTI e tractography, cruzadas 
individualmente com os termos simple phobia e specific	phobia. Foram encontrados 115 artigos, 
sendo 38 deles selecionados para a presente revisão. Desses, 24 usaram fMRI, 11 usaram PET, 1 
usou SPECT, 2 usaram MRI estrutural e nenhum artigo de espectroscopia. Verifica-se que os estudos 
na área foram publicados recentemente e que, até o momento, o substrato neuroanatômico 
deste transtorno não está consolidado. Apesar das diferenças metodológicas entre os estudos, 
os resultados convergem para maior ativação na ínsula, cíngulo anterior, amídala e córtex pré-
frontal e orbitofrontal dos pacientes expostos a situações phobia related quando comparados aos 
controles. Esses achados reforçam hipóteses a respeito da hiperativação de uma determinada 
rede de estruturas neuroanatômicas envolvidas no transtorno de SP. 
©2012 Elsevier Editora Ltda. Todos os direitos reservados.
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Introduction
Specific phobia (SP), or simple phobia, is an anxiety disor-
der characterized by increased and persistent excessive or 
irrational fear in the presence or anticipation of an object 
or phobic situation causing, almost invariably, an immedi-
ate anxiety response (DSM-IVR – APA, 2000).1 DSM-IV defined 
five subtypes of SP: animal, natural environment, blood-
injection-injury (BII), situational, and others. Specific phobias 
are considered the most frequent anxiety disorders and are 
among the most common psychiatric disorders in general 
population, with a prevalence of about 12.5%.2 
Although environmental, constitutional, and genetic fac-
tors are believed to contribute to the pathogenesis of the 
disorder,3-5 little attention had been dedicated to the study of 
SP neurobiology and etiology. The neuroimaging techniques, 
in particular, have helped to deepen the understanding of the 
neural circuitry underlying SP. Since its advent, neuroimaging 
has enabled the in vivo analysis of anatomical and functional 
structures, as well as analyses of regional metabolism in 
different psychiatric disorders. Methods like magnetic reso-
nance imaging (MRI), functional magnetic resonance imag-
ing (fMRI), positron emission tomography (PET), and single 
photon emission computed tomography (SPECT) have been 
used in the investigation of biological processes involved in 
the neurocircuitry of SP. 
In order to expose a panoramic view to the readers, 
this article presents a systematic qualitative review of 
published studies on neuroimaging of patients with SP. 
The qualitative approach was chosen because quantita-
tive methods, such as meta-analysis, show that: (a) the 
information necessary to calculate result size is not always 
available, and may limit this analysis to a small subset of 
studies;6 (b) methods and extent of detailed information 
to define regions of interest vary greatly among studies, 
hindering accurate comparisons; (c) there are great dif-
ferences regarding secondary variables in studies (for 
instance, gender, medication, co-morbidity, SP subsets); 
(d) studies used different functional (PET, SPECT, fMRI, 
relaxometry) and structural (MRI) neuroimaging methods, 
which precludes comparative statistical analyses; (e) dif-
ferent methods are used to analyze images (automatic 
vs. ROI) in different forms of investigation, and (f) meta-
analyses have intrinsic limitations in estimating negative 
results which are not published (the file drawer problem;7). 
Thus, a quantitative analysis is not adequate for a review 
with large amplitude (with no time limit set). Finally, it is 
relevant to point out that although animal research is valu-
able to understanding anxiety disorders, the current study 
will focus only on research performed with humans, as the 
analysis of animal research is beyond the scope proposed.
Method
Searches were performed in LILACS, SciElo and Web of 
Science databases, using the following key words: imag-
ing, neuroimaging, PET, spectroscopy, functional magnetic 
resonance, structural magnetic resonance’, SPECT, MRI, DTI 
e tractography, individually crossed with the terms simple 
phobia and specific phobia. Additional articles were sought 
manually in references from previously selected material.
The inclusion criteria for the articles used in the cur-
rent study were: complete and original articles; in English; 
with samples of patients whose main diagnosis was SP 
and who had undergone investigation using neuroimaging 
techniques. No time limit was established, having the last 
search been performed in April, 2011. The search found 
115 articles, of which 38 were selected to compose the 
present review (Figure 1).
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Results
From the 38 studies included in this review, 24 used fMRI, 11 
used PET, 1 used SPECT, and 2 used MRI (cortical thickness). 
None of them used MRS, VBM techniques, or Graph analysis. 
For heuristic reasons, the articles will be grouped according 
to the neuroimaging techniques applied. 
Structural magnetic resonance: Cortical Thickness
To the best of our knowledge, only two articles used MRI. 
One of the studies, while investigating cortical thickness of 
subjects with animal phobia and healthy volunteers, found 
that when compared to control, the SP group presented 
increased thickness in the insular bilateral cortex, bilateral 
pregenual anterior cingulum, bilateral posterior cingulate 
cortex, and left visual cortex.8 
The other study investigated the existence of correla-
tion between the degree of anxiety sensitivity and cortical 
thickness of the right anterior insula in patients with animal 
phobia and healthy individuals. The authors observed that 
patients presented high anxiety scores compared to controls, 
however, there was no difference in cortical thickness or 
insula volume in both groups9 (Table 1).
The reduced number of participants in the studies, the 
need to assess volumetric differences in structures knowingly 
implicated in SP, such as the hippocampus and subcortical 
structures, and the absence of other articles using VBM in 
SP make the continuation of complementary studies in the 
area an issue of paramount importance.
Positron emission tomography (PET)
The first studies that sought to investigate the neuroanatomic 
substrate of SP made use of PET. By using tracers marked with 
a radioactive isotope, the technique provides brain activity 
assessment. To date, eleven articles that made use of PET 
in SP were found. The first study using PET in SP did not find 
significant differences between patients with animal phobia 
and healthy volunteers.10 However, subsequent studies have 
shown changes in rCBF (regional cerebral blood flow) in 
paralimbic and sensory regions. Female patients with snake 
phobia11-13 and spider phobia12,14 were shown phobia-related 
images, neutral images, and aversive images unrelated to 
phobia. Significant increase was found in rCBF in the visual 
cortex,13,14 amygdala, thalamus, and striatum12 and reduced 
rCBF in the orbitofrontal cortex, temporopolar cortex, pos-
terior cingulate cortex, and hippocampus.11,14
With the same experimental group of sixteen phobic 
subjects, a study tried to replicate some of the results 
previously described,15 and another study investigated the 
activity of the NK1 receptor system (neuropeptide substance 
P binds to the neurokinin receptor SP-NK1) of the amygdale.16 
Viewing phobia-related images was correlated with increased 
activation of the right amygdala, cerebellum, left visual 
cortex, and circumscribed frontal areas. Decreased activity 
of prefrontal, orbitofrontal, ventromedial, somatosensso-
rial, and hearing cortices was observed. Additionally, during 
non-aversive stimulation, prefrontal activity was negatively 
correlated with rCBF of the amygdala. These results suggest 
that phobic reactions activate areas of object recognition 
and deactivate prefrontal areas involved in cognitive control 
of emotions, triggering areas like the amygdala, related 
to motor readiness for fight or flight.15 The second study 
observed that the antagonist reuptake in SP-NK1 receptors 
was significantly reduced in the right amygdala during pho-
bic stimulation, suggesting a decrease in the availability of 
NK1 receptors, which may reflect the increased release of 
endogenous substance P.16
Table 1 Structural Magnetic Ressonance studies in SP
Name Subjects (n) F/M Age (m ± SD ) Handedness Sample Procedure T Results (SP > controls)
Rauch et al. 8 10 SP- animal 
20 controls 
4-6
8-12
32.1 ±1 1.6 
28.6 ± 6.5
Right-handed
Right-handed
Comorbidity: no.
Medication: free
Regional cortical thickness 
to investigate structural 
abnormalities
1.5 SP: ↑ cortical thickness of 
paralimbic cortex, sensory 
cortex (bilateral insular, bilateral 
pregenual anterior, cingulated, 
posterior cingulated, visual 
cortical regions)
Rosso et al. 9 19 SP - animal 
20 SP - controls
14-5
11-9
28.68 ± 6.36
29.70 ± 6.22
Right-handed Comorbidity: no.
Medication: free
Regression and correlation 
analyses examined anxiety 
sensitivity scores in relation 
to anterior and posterior 
insular cortex volume and 
thickness
3.0 SP: ↑ anxiety scores than controls 
but did not differ volumes or 
thickness of insula Anxiety scores 
predicted ↑ thickness of the right 
anterior insular cortex in SP group
↓, decrease; ↑, increase; F, female; M, male; SD, standard deviation; m, mean; SP, specific phobia
Figure 1 Flow chart showing study selection for the review.
MEDLINE/ISI search keyword
(n = 115)
Studies included in this review
(n = 38)
Studies that in vestigated the SP 
using neuroimaging
(n = 38)*
Excluded:
• Did not use MRI (n = 25)
• Other disorders than SP (n = 26)
• Review (n = 8)
• Letter to the reader (n = 1)
• Case and brief reports (n = 2)
• Comorbid condition (n = 10)
• Meta-analysis (n = 1)
• Animal (n = 2)
• Genetics (n = 1)
• Not in english (n = 1)
* two additional reference was found after hand-searching basead on these articles
RBP -  02.indb   103 07/02/2012   15:57:52
104 I.M.P. Linares et al.
In tasks related to the imagination17 and anticipatory 
anxiety18 participants with small animal phobia showed in-
creased rCBF in the anterior cingulate cortex, insular cortex, 
anterior temporal cortex, and somatosensory cortex17 and 
decreased rCBF in the primary visual cortex.18 The authors 
suggest the existence of a neurophysiologic correlate of 
avoidant anticipatory coping.
Brain activation during aversive modulation in phobics 
through pairing phobia-related and neutral images to an 
aversive noise was investigated.19 There was an increase in 
ACC and in the left hippocampal-amygdaloid area activa-
tion during exposure to phobia-related images associated 
with aversive noise. This raised the hypothesis that these 
two regions could be part of a neural system connected to 
attention and danger orientation.
Habituation to feared stimuli has also been studied.20 The 
referred protocol caused a decrease in anxiety measured 
by SUD-S and regression analyses showed that anxiety was 
correlated to increased activity in left amygdala, perirhinal 
bilateral cortex, right FG, and periaquedutal gray matter. In 
its turn, phobic fear seems to be associated with increased 
right hippocampus activity. While habituation to stimuli 
promoted a decrease of physiologic and subjective anxiety, 
administration of diazepam did not affect the rCBF of sub-
jects with phobia.14 Table 2 provides detailed information 
on methodologic studies with PET included in this review.
Single photon emission tomography (SPECT) 
This technique is used in the investigation of brain activity 
through tracers marked with a single photon emitter. SPECT 
has been little used in the study of SP, the only study that 
applied the SPECT technique to SP (Table 3) investigated 
whether brain changes associated with increases in anxiety 
states are different from those observed during a cognitive 
activation experiment.21 Participants underwent two tests: 
one in which they would hear audio with relaxing content, 
and another in which they would hear phobia-related audio 
content. Psychophysiologic and subjective measures showed 
substantial changes in the induction of fear. Additionally, a 
decrease in the radiotracer reuptake in regions of bilateral 
occipital cortex, right posterior temporal cortex, and right 
anterior cingulate cortex could be observed.
Functional magnetic resonance imaging (fMRI)
Currently, fMRI is the most widely used neuroimaging meth-
odology in the study of SP. So far, twenty four studies were 
conducted in order to better understand the neurobiology 
of SP, five of these related to psychotherapeutic treatment of 
the disorder. In the study of SP, the predominance of this 
technique over the others can be attributed to the fact 
that it provides data on brain functioning pattern with high 
temporal solution and greater patient safety, as it does not 
make use of radioisotopes. 
One of the first studies to use fMRI to investigate SP was 
conducted by Wright et al. (2003).22 At that moment, studies 
pointed at an increase in brain activity in sensory areas and 
increase or decrease in anterior and hippocampal paralimbic 
regions.11,13,14,17 However, studies on SP did not show amygdala 
hyperresponsivity against a phobic stimulus. Similarly, Wright 
et al. (2003)22 assessed the amygdala response to emotional 
faces versus neutral faces in subjects with animal phobia and 
in healthy individuals. Authors did not find significant differ-
ences regarding amygdala activation; however, consistently 
with other studies,17,23,24 they observed an increase in the 
response of right insular cortex in phobic individuals exposed 
to aversive images. This insular activation occurred after the 
introduction of stimuli that represented threat but were not 
particular to the disorder.
Contrary to these findings, several subsequent studies 
consistently observed changes in amygdala activation of 
individuals with arachnophobia exposed to phobia-related 
images.24-28 In general, studies have observed increase in 
amygdala activation,24,26-29 and in one study this response was 
also confirmed upon exposure of images related to the feeling 
of disgust.27 Additionally, increase has been confirmed in insula 
activation,22,24,26-28 orbitofrontal cortex and uncus,24 associative 
visual cortex, DLPFC, hippocampus,25 bilateral ACC,26,27 pre-
frontal medial cortex, thalamus,26 thalamus pulvinar nucleus, 
and supplementary motor area.27 These findings suggest that 
the amygdala has a relevant role in fear processing, and they 
also suggest brain activation patterns when phobic individuals 
are confronted with phobia-related stimuli.
Still trying to clarify the role of the amygdala in SP, Alpers 
et al. (2009)30 investigated if the attribution of attention to 
overlap images modulates the activation of this structure. 
Authors observed increase in amygdala activation of subjects 
with phobia in response to mixed images (spider and bird), 
static or in movement. It is also relevant to highlight that 
the amygdala activation happened in a dose-response rela-
tion, which means the higher the exposure to the feared 
stimulus the greater the structure activation. Larson et al. 
(2006),31 while investigating the time of amygdala activation 
of individuals with fear of spiders, observed shorter starting 
time for the activation peak in this brain region. That means 
phobic individuals presented intense and short responses in 
the amygdala, while the control group presented weaker and 
sustained responses. These findings confirm the involvement 
of the amygdala in the processing of phobia-relevant stimuli.
Although a central role in the pathophysiology of SP has 
been attributed to the amygdala, some studies have inves-
tigated the relationship among other brain regions in SP. 
Martis et al. (2004)32 exposed phobic individuals and healthy 
participants to a “serial reaction time task paradigm” in or-
der to investigate an implicit learning sequence. During the 
implicit learning sequence, significant differences between 
patients and control group concerning striatum activation 
were not found. The existence of different pathophysiological 
mechanisms when comparing SP to other disorders was sug-
gested; in obsessive compulsive disorder (OCD), for instance, 
striatum activation was decreased in patients.33 
Along another line of evidence, two studies described the 
relationship between attention and activation of brain struc-
tures in subjects with SP.34,35 Subjects with animal phobia took 
the “Counting Stroop” test and showed increased activation 
in rostral ACC specifically when exposed to a phobia-related 
situation. In the control group, there was increased activity in 
the right amygdala and posterior insula and decrease in thala-
mus activity. In both groups there was increased activation 
in ACC, dorsomedial prefrontal cortex, inferior frontal gyrus, 
insula and amygdala, as well as thalamus deactivation.34 It 
was suggested that these findings imply a circuit of dysfunc-
tion, which is linked to attention abnormalities in individuals 
RBP -  02.indb   104 07/02/2012   15:57:53
105Neuroimaging in specific phobia disorder: a systematic review of the literature
Table 2 Positron Emission Tomography (PET) studies in SP
Name Subjects (n) F/M Age (m ± SD) Handedness Sample Procedure Radiotracer Results (SP>controls)
Mountz  
et al. 10
7 SP animal
8 controls
7-0
8-0
24 to 44 Right-handed Comorbidity: no.
Medication: free
PET (rest/ fear repeated 
measures paradigm) ROI
H2 
15O rCBF No differences on rCBF values between SP and controls SP: ↑ objective and 
subjective anxiety (STAI and SUD-S) heart rate and respiratory rate during 
SP stimulation
Wik et al.11 6 SP snake 6-0 27 ± 7.4 Not stated Comorbidity: no.
Medication: free
PET (SP-relevant, aversive 
and neutral scenes)
15O-butanol SP: ↑ rCBF in the secondary visual cortex ↓ rCBF in the hippocampus, 
orbitofrontal, prefrontal, temporopolar and posterior cigulate cortex during 
phobogenic visual scenes
Fredrikson  
et al. 13
6 SP snake 6-0 19 to 27 Not stated Comorbidity: no.
Medication: free
PET (SP-relevant, aversive 
and neutral scenes)
15O-butanol SP: ↑ rCBF in the secondary visual cortex ↑ rCBF in occipital regions 
during phobic stimulation. Cortical and thalamic rCBF were correlated 
during SP stimulation
Fredrikson  
et al. 14
8 SP spider 8-0 29 ± 5.5 Not stated Comorbidity: no.
Medication: free
PET: Videotape (SP-
relevantant/ neutral 
scenes) or 0.1 mg/Kg 
Diazepam or glucose + 
PET: videotape
15O-butanol SP: ↑ rCBF in the secondary visual cortex ↓ rCBF hippocampus, prefrontal, 
orbitofrontal, temporopolar, posterior cingulate córtex Diazepam did not 
affect the relative rCBF or subjective and physiological fear indices
Rauch  
et al. 17
4 SP 6-1 37 ± 10.3 Right-handed Comorbidity: no.
Medication: free
PET (touch the container 
of innocuous and 
provocative stimulus) ROI
15O-labeled CO2 SP:↑ rCBF for symptomatic state compared with the control state in ACC, 
left insular cortex, right anterior temporal cortex, left somatosensory 
cortex, posterior medial orbitofrontal cortex, left thalamus
Wik et al. 18 14 SP spider/
snake 
6 controls
14-0
6-0
28 ± 6.4
32 ± 7.5
Not stated Comorbidity: no.
Medication: free
PET-scanned (neutral 
scenes videotape) 
anticipated fear
H2 
15O rCBF SP:↓ primary visual cortex rCBF 
Wik et al. 12 14 SP spider/
snake
6 controls
14-0
6-0
28 ± 6.4
32 ± 7.5
Not stated Comorbidity: no.
Medication: free
PET (SP-relevant,aversive 
and neutral scenes)
H2 
15O rCBF SP and controls↑ brain synchronization during fearful state of SP reaction, 
but not in resting state SP:↑ rCBFamygdala, the thalamus, and the 
striatum activation
Pissiota  
et al. 19
8 SP spider
8 SP snake
16 controls
16-0 22.7 ± 4.1 Right-handed Comorbidity: no.
Medication: free
PET + Startle modulation 
(acoustic stimulation) 
paired with spider/ snake/
blank pictures
H2 
15O rCBF SP:↑ rCBF medial ACC and left amygdaloid-hypocampal region during 
phobic stimuli
Veltman  
et al. 20
12 SP spider
6 controls
11-1
4-2
32.1 ± 14.1
30.5 ± 10.9
Not stated Comorbidity: no.
Medication: free
PET + 9 series of 9 blocks 
pictures (phobic and 
neutral content) and SUDS 
after each block
H2 
15O rCBF SPx neutral before habituation - SP: activation of left fusiform, right 
parahippocampal gyrus, bilateral  perirhinal cortex, right limbic areas, 
right lateral, prefrontal cortex, , right pulvinar, right posterior insula, 
amydalar region. After Habituation- SP: ↓ activation of bilateral anterior 
medial temporal lobe, right medial, right amygdala, posterior insula, right 
hypothalamus SUDS: correlated with activation in left amygdala and perirhinal 
cortex, bilaterally, in the right fusiform gyrus, and periaquaductal gray
Michelgård  
et al. 16
8 SP spider
8SP snake
16-0 22.75 ± 4.1 Right-handed Comorbidity: no.
Medication: free
2 PET scans/person one 
week apart (NK1  receptor 
system) + pictures 
(feared, non-feared 
animals) and STAI after 
PET 1 day with SP and 1 
with non-SP stimulation
11C-GR205171 
(NK1 receptor 
antagonist)
H2 
15O rCBF
SP: ↓uptake of NK1 receptor antagonist in the right amygdala during phobic 
stimulation. Negative correlation in the right amygdala between subjective 
anxiety ratings and NK1 tracer binding
Ash et al. 15 8 SP spider
8SP snake
16-0 22.8 ± 4.1 Right-handed Comorbidity: no.
Medication: free
PET (SP, fear-relevant, 
non-phobic pictures)+ 
behavioral tests
H2 
15O rCBF SP:↑ right amygdala, cerebellum, left visual cortex and circumscribed 
frontal areas activation ↓ prefrontal, orbitofrontal and ventromedial 
cortices, primary somatosensory cortex and auditory cortices activation
↓, decrease; ↑, increase; F, female; M, male; SD, standard deviation; m, mean; SP, specific phobia; ROI, region of interest; SUDS, Subjective Units of Distress Scale; NK1,neurokinin 1 receptor ;  
rCBF, regional cerebral blood flow; STAI, Spielberger Trait.
with SP. Another study showed an increase in the activation 
of the amygdala, insula, ACC, and DMPFC (dorsomedial pre-
frontal cortex) during the identification task, and bilateral 
activation in the amygdala of phobics during the “distrac-
tion task”.35 Notably, in the face of phobia-related stimuli, 
amygdala activation was observed independently of attention 
resources, unlike the activation of ACC, DMPFC, and insula 
that were dependent on the resources of attention.35,36 This 
finding was reproduced in a later study,23 which investigated 
the defensive response mobilization. These data suggest 
that the activation of the amygdala in fMRI studies primar-
ily indexes the detection of motivationally relevant stimuli, 
whereas the insula might be more specifically connected to 
defensive response mobilization.
Besides attention, memory and anticipatory anxiety in SP 
have also been studied.37,38 In the 2004 study, the presentation 
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of phobia-related words was related to increased activation 
in prefrontal cortex, insula, and posterior cingulate cortex of 
subjects with phobia compared to healthy subjects. A neural 
network for the processing of these threatening stimuli was 
suggested. Confirming some of the results already described, 
in 2007 Straube reported an increase in activation of the 
dorsal ACC, insula, thalamus, and visual areas in phobic in-
dividuals during an anticipatory stimulus of phobia relevant 
images compared to the anticipatory stimulus of neutral 
pictures. This study provided evidence for the hypothesis 
that there is increased activation in specific brain regions 
during anticipatory anxiety in individuals with SP.
Assuming that SP is characterized by a deficit in the 
automatic regulation of emotions, fourteen subjects with 
spider phobia were assessed while visualizing phobia-related 
and aversive images; then, individuals were asked to up- and 
down-regulate the emotions elicited by the images. An in-
crease was observed in the activation of the insula, as well 
as a decrease in activation of the ventromedial prefrontal 
cortex of patients, suggesting they have deficits in both 
automatic and effortful regulation of emotions elicited by 
phobic compared with aversive stimuli.39
Most studies on SP and neuroimaging concern the animal 
subtype;therefore, little is known about the neurocircuitry 
related to other subtypes of phobia. Herman et al. (2007)40 
examined the effects of symptom induction in the neural 
activation of individuals with BII phobia. When compared to 
the control group, there was decreased activity in the medial 
prefrontal cortex and increased activation of the supplemen-
tary motor area in the BII group exposed to phobia-related 
images. The results might reflect reduced cognitive control 
of emotions in BII phobic individuals during the experience 
of phobic symptoms as well as during states of disgust.
Some studies have compared the neurocircuitry of 
healthy individuals to that of patients with animal and BII 
phobia subtypes. Lueken et al. (2011)41 observed greater 
activation of structures such as ACC, insula, and thalamus 
in individuals with the animal phobia subtype, unlike indi-
viduals with BII phobia that had circumscribed activation 
in the prefrontal and orbitofrontal cortices. Caseras et al. 
(2010)42 observed similar activation in brain structures, such 
as the occipitotemporal region and thalamus, in both groups 
with SP. Individuals with spider phobia showed activation of 
bilateral dorsal ACC, anterior insula, inferior frontal gyrus, 
and visual cortex; however, compared with BII phobics, there 
was reduced activation of the medial frontal cortex extend-
ing later to the rostral ACC and greater activation in dorsal 
anterior cingulus and anterior insula. When viewing images 
of blood-injection-injury, the BII phobics showed increased 
activation in the thalamus and occipitotemporoparietal 
cortex compared to the other two groups.
The results described suggest partially distinct neurobio-
logical substrates between animal and BII phobic subtypes; 
thus, Caseras et al. (2010b)43 sought to evaluate if by the 
display of phobia-related images, the BII group would present 
different responses in the insula and ACC compared to those 
with spider phobia. The BII group showed higher activity of 
ventral prefrontal cortex compared to control, and reduced 
peak activity in left amygdala compared to those with spider 
phobia. Similarly, both groups took long time to reach the 
peak of activation in the right amygdala, but only the spider 
phobia group showed significant changes for this parameter 
in the left amygdala compared to control group. In contrast 
to previous findings, no differences were found in the insula 
and ACC activity in patients with BII phobia and spider phobia. 
Considering these and other previous results, the authors 
suggest that the two phobia subtypes (spider and BII) showed 
similar responses when exposed to phobia-related pictures; 
however, there are significant differences in their sustained 
responses to these stimuli.
As for the pharmacotherapy of the disorder, there is a 
limited number of studies that investigated the neuronal ef-
fect of drugs in people with SP. The effects of D-cycloserine 
(DCS-a partial agonist to NMDA receptors) were assessed in 
patients with spider phobia.44 The authors found that patients 
with phobia who received DCS showed increased activation 
of the PFC, dorsal ACC, and insula during exposure to phobia-
related images. Still, the placebo group showed a positive 
correlation between lateral PFC and amygdala activation. 
Results suggest that during the initial phobic symptom in-
ducement, DCS increases activation in regions involved in 
cognitive control and interoceptive integration.
Some studies have used fMRI in order to investigate the 
main effects of psychotherapy on SP. Spider phobia patients 
underwent fMRI before and after four45 and two psycho-
therapy (CBT - Cognitive Behavioral Therapy) sessions.28 Upon 
exposure to phobia-related images in the first examination, 
there was increased activity in the parahippocampal gyrus, 
associative visual cortex, and right dorsolateral prefrontal 
cortex of subjects with phobia45 and increased amygdala 
activity compared to controls.28 After CBT phobic subjects 
showed decreased symptoms and increased activity in areas, 
such as associative visual cortex, superior parietal lobule, 
bilateral inferior frontal gyrus, absence of parahippocampal 
gyrus, and right dorsolateral prefrontal cortex activation.45 
Additionally, there is a decrease in amygdala, insula, and 
ACC hyperactivity.28 These findings suggest that the CBT 
psychotherapeutic treatment has the potential to modify the 
dysfunctional neural circuitry associated with SP.
Other studies related to psychotherapy and SP were per-
formed in which participants were divided into controls, sub-
jects with arachnophobia on the waiting list, and individuals 
Table 3 Single Positron Emission Tomography (SPECT) study in SP
Name Subjects (n) F/M Age (m ± SD) Handedness Sample Radiotracer Drug Procedure Results (SP>controls)
O’Carrol 
et al. 21
10 SP 9-1 51 ± 15.1 Right-handed Comorbidity: no.
Medication: free
99mTc-HMPAO/rCBF Volunteers 
listened relaxing 
tape/ phobic 
tape + SPECT
↓ tracer uptake in 
posterior regions ↓ right 
temporal/ occipital 
regions and left ACC
↓, decrease; ↑, increase; F, female; M, male; SD, standard deviation; m, mean; SP, specific phobia; rCBF, regional cerebral blood flow; STAI, Spielberger Trait.
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with spider phobia who underwent CBT – psychotherapy.29,46 
Upon exposure to neutral, disgust, fear and phobia-related 
images, brain activation in the first fMRI session did not dif-
fer between the two groups with phobia in which there was 
increased activation in the insula, ACC29,46 parahippocampal 
gyrus, amygdala, and lateral orbitofrontal cortex29 compared 
to control group. In the second fMRI scan, after one and two 
psychotherapy sessions,29 there was decreased activity of 
the insula,29,46 amygdala,29,46 and ACC46 and increased activa-
tion in the medial orbitofrontal cortex29 in the group that 
underwent psychotherapy compared to waiting list group. 
The authors concluded that successful treatment of SP is 
primarily accompanied by functional changes of the medial 
OFC (orbitofrontal cortex), a key brain region for the self 
regulation of emotions and the relearning of stimulus rein-
forcement associations. Straube claims that reducing the 
activity of the insula and ACC may reflect the attenuation 
of the phobic response after treatment.
 In an attempt to prove the efficacy of CBT after six 
months of treatment, Schienle et al. (2009)47 once again 
exposed ten participants from their previous study29 to the 
same sequence of photos and performed fMRI scans. It was 
observed that the psychotherapy group showed a decrease 
of clinical symptoms. Moreover, when comparing results of 
the first and second fMRI sessions, there is increased activity 
of the medial orbitofrontal cortex, and decreased activity in 
the insula and lateralorbitofrontal cortex. The authors high-
lighted that the results of the medial OFC would be related 
to the neural basis of the lasting positive outcome of CBT.
Consistent evidence resulting from the change of brain 
functioning in SP has been observed by fMRI studies with 
predominance of limbic structures, especially the amygdala, 
insula, and ACC. It is likely that the correlation between the 
findings is largely due to the experimental procedures used 
in examining the emotional processing in SP, despite having 
different goals and specific methodology. 
Discussion
Neuroimaging may be considered an important technique 
to help understand the anatomical, functional and meta-
bolic neurocircuitry underlying the pathophysiology of SP. 
Most of the studies analyzed in this review used functional 
neuroimaging techniques to assess brain response against 
exposure to phobia-related images, and results consistently 
point to activation mainly in the amygdala, ACC, and insular 
cortex (Figure 2). Despite the high prevalence of SP in the 
general population,2 only two MRI studies on the disorder 
were found: cortical thickness8 and SPECT.21 Also, in contrast 
to the numerous studies of other anxiety disorders, such 
as obsessive compulsive disorder (OCD) and post traumatic 
stress disorder (PTSD), no studies on SP have been performed 
with techniques such as MRI/VBM, MRS, and graph analysis.48
Contrary to panic disorder or OCD, there is still no de-
finitive model for the neuroanatomical substrate of SP. One 
possibility is that they are learned, characterized by fear 
conditioned to a stimulus or situation. Moreover, the phobias 
may be due to dysregulation of systems that are specific for 
the detection of stimuli or threatening situations.49
Experimental evidence indicates the existence of specific 
neural circuits that modulate emotional behavior, which 
responds according to the nature of the stimulus to which 
the individual is exposed. The Brain Aversive System (BAS), 
represented by the medial hypothalamus, the dorsal periaq-
ueductal gray matter; and the amygdala, would be associated 
with the emission of unconditioned responses (innate and not 
learned); for example, elevated blood pressure, increased 
heart rate and breathing, piloerection, urination, defeca-
tion, and exophthalmos.50,51 There are hints that anatomic 
and functional abnormalities connected to the Behavioral 
Inhibition System (BIS) could cause abnormal defense reac-
tions, such as panic attacks and phobic symptoms develop-
ment.52 It is believed that the organization of conditioned 
responses is carried out by the BIS, represented by the septo-
hippocampal system, the median raphe nucleus, and ventral 
periaqueductal gray matter.53 It is known that the amygdala 
is involved in the activation of both BAS and BIS, acting as 
the primary interface between both.54,55
The amygdala seems to play a key role in the neurobiol-
ogy of anxiety disorders in general and particularly in SP. The 
first neuroimaging studies on SP explored patterns of brain 
activity in phobic symptoms caused by visual stimuli,11,13,14,56 
tactile stimuli,10,17 or auditory cues.21 The initial hypothesis 
was that the amygdala, with its role in surveillance and 
negative affection, would show increased activity during 
fear inducement.10,13,17 In fact, several studies have demon-
strated greater activation of this structure in patients with 
SP.20,23-25,27-29,34,35,44 However, some studies failed to show this 
increased activity of the amygdale.12,18,22,31,37,40,45,57 It is pos-
sible that these negative results are due to methodological 
differences between studies, such as time of exposure to the 
phobia-related stimulus and the cognitive/emotional nature 
of the task applied.24
Other structures that showed hyperactivity in phobic 
individuals exposed to phobia-related stimuli were the 
anterior insula, hippocampus, dorsal and rostral ACC, and 
somatosensory and occipitoparietal cortex.6,24,25,27,29,35,46 In 
particular, the ACC (anterior cingulate córtex) has numer-
ous subdivisions that perform cognitive, emotional, motor, 
nociceptive, and visual-spatial functions58 and is connected 
to the amygdala, periaqueductal gray matter, accumbens 
nucleus, hypothalamus, anterior insula, hippocampus, and 
orbitofrontal cortex.59 The dorsal ACC is mainly involved in 
assessing information of emotional and motivational nature, 
Figure 2 Figurative summary of the major findings of the 
reviewed studies (number of studies/total number of studies) 
ACC - Anterior Cingulate Cortex, PFC - Prefrontal Cortex.
PFC
(11/38)
ACC
(13/38)
Amygdala
(16/38)
Insular Cortex
(18/38)
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Table 4 Functional Magnetic Resonance Imaging (fMRI) studies in SP
Name Subjects (n) F/M Age (m ± SD) Handedness Sample T Procedure Results (SP>controls)
Paquette et al. 45 12 SP spider
13 controls
12-0
13-0
24.8 ± 4.5
28.6 ± 7.8
Not stated Comorbidity: no. 1.5 fMRI (five 30s films: spider, neutral) +CBT (4 
sessions)/ self-exposure homework+ fMRI - ROI
1st fMRI- SP: ↑ right dorsolateral prefrontal cortex, 
parahippocampal gyrus bilaterally left inferior occipital gyrus, 
left fusiform gyrus and right occipital gyrus 2nd fMRI- SP: 
middle occipital gyrus bilaterally. No activation in dorsolateral 
prefrontal cortex or parahippocampal gyrus
Wright et al. 22 10 SP animal
10 controls
6-4
6-4
29.8 ± 6.8
28.7 ± 11.1
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/ BOLD (emotionally-valenced faces pictures - 
happy, fearful, neutral and fixation blocks) ROI
SP x controls- SP:↑ response to the fearful x neutral faces in 
right insular cortex No significance between-group in amygdala 
activation
Dilger et al. 24 9 SP spider 
9 controls
9-0
9-0
25 ± 2.3
21.3 ± 0.6
Not stated Comorbidity: no.
Medication: free
1.5 fMRI/ BOLD (SP-relevant, neutral and fear-inducing 
pictures) ROI
SP-relevant pictures: SP:↑ amygdala insula, orbitofrontal 
cortex and uncus activation 
Martis et al. 32 10 SP animal 
10 controls
6-4
6-4
29.8 ± 6.8
26.7 ± 6.7
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/BOLD +serial reaction time task paradigm ROI SP and controls: activation in the right striatum, left thalamus, 
right caudate, right putamen, left insula and mid-cingulated 
cortex, bilaterally No main effects of diagnosis or diagnosis-by-
condition interactions
Straube et al. 38 11 SP spider
11 controls
11-0
11-0
20.8
22.4
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/ BOLD + word stimuli (SP-relevant, neutral 
words) ROI
SP- SP-relevant words: ↑ left prefrontal cortex, bilateral insula 
and bilateral inferior frontal gyrus activation
Schienle et al. 25 10 SP spider
13 controls
10-0
13-0
22.5 ± 2.2
23.9 ± 6.9
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI (SP-relevant, generally fear-inducing, disgust-
inducing and affectively neutral pictures) / ROI
SP- SP-related pictures: ↑ visual association cortex, right 
DLPFC, right parahippocampal gyrus, left fusiform gyrus, 
amygdala bilaterally activation
Larson et al. 31 13 SP spider
14 controls
13-0
14-0
18.46 ± 0.52
19.21 ± 1.02
Right-handed Comorbidity: no. 1.5 fMRI/ BOLD (spider,non-spider negative, neutral 
pictures) time to onset, percent signal change from 
baseline and time to peak activation. ROI
SP- spider pictures: ↑ amygdala activation /faster time to 
onset and time to peak of responses Controls: sustained and 
weaker responses
Straube et al. 46 13 SP therapy group (TG)
12 SP waiting list (WL)
14 controls
13-0
12-0
14-0
21.92 ± 2.02
21.33 ± 2.46
22.07 ± 1.98
Not stated Comorbidity: no.
Medication: free
1.5 fMRI (SP-relevant, neutral pictures)+ TG (two-
session) or WL+ fMRI (SP-relevant, neutral videos) + 
behavioral tests. ROI
1st fMRI- TG and WL: brain activation did not differ between 
both groups SP - SP-videos:↑ insula and ACC bilaterally, left 
extra striate visual cortex activation 2nd fMRI TG x WL: insula 
and ACC hyperactivity bilaterally. TG: ↓ ventral anterior insula 
activation
Straube et al. 35 11SP spider
12 controls
11-0
12-0
20.9 ± 2.3
21.3 ± 0.6
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI / BOLD (SP-relevant in neutral pictures) + 
identification task/ demanding distraction task. ROI
Identification task- SP:↑left amygdala, left insula, left ACC, 
and left DMPFC Distraction task -SP:↑ left and right amygdala
Goossens et al. 27 15 SP spider
14 controls
13-2
12-2
24 ± 2
23 ± 1
Right-handed Comorbidity: no.
Medication: free
3.0 fMRI/ BOLD (SP-relevant, potentially fear-relevant, 
and neutral pictures) ROI
SP -relevant pictures: SP: ↑left amygdala, thalamic pulvinar 
nucleus bilaterally, ACC, left insular cortex and bilaterally in 
supplementary motor area activity
Goossens et al. 28 16 SP spider
14 controls
16-0
12-2
24 ± 3.02
Not stated
Right-handed Comorbidity: no. 3.0 fMRI/BOLD (SP-relevant, potentially fear-relevant 
and neutral pictures) + 1 CBT session + fMRI. VAS 
after each fMRI. ROI
1st fMRI: SP: ↑ amygdala activity bilaterally in the ACC and 
in left insula. 2nd fMRI: SP: ↓ amygdala,  ACC and insula 
hyperactivity. VAS correlated with amygdala activation
Straube et al. 37 16 SP spider 
15 controls
16-0
15-0
21.8 ± 0.6
22.7 ± 0.9
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI (SP and neutral pictures) + each picture was 
preceded by an anticipatory period and symbol. ROI
SP: ↑ dorsal ACC, insula, thalamus, BNST and visual areas 
activation during anticipation of phobia-relevant x anticipation 
of neutral stimulation
Hermann et al. 40 9 SP BII
10 control
9-0
10-0
22.9 ± 4.7
27.6 ± 10.6
Not stated Comorbidity: no.
Medication: free
1.5 Day 1 - behavioral tests Day II - fMRI/ BOLD SP, 
disgust, fear, neutral pictures). ROI
SP and disgusting pictures: SP: ↓ MPFC activity. SP x neutral 
pictures: SP: ↑left hippocampus and bilateral thalamus Fear x 
neutral: SP: ↑ right amygdala activity
Schienle et al. 29 14 SP therapy group
12 SP waiting list
25 controls
14-0
12-0
25-0
27.2 ± 9.2
24.3 ± 2.0
24.6 ± 6.3
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/BOLD (SP-relevant, disgust-relevant, 
threatening and neutral pictures)+ TG (one-session) 
or WL+ fMRI. ROI
1st fMRI: no differences between TG and WG. ↑ left amygdala 
and bilateral fusiform gyrus activation, ↓ medial orbitofrontal 
cortex, right DLPFC activation , bilateral ACC, right inferior 
parietal gyrus Controls: ↑ bilateral angular gyrus, right lingual 
gyrus and left ACC 2nd fMRI: TG↓ right insula activation from 
1st to 2nd session ↑ medial OFC activity in TG relative to WG 
WL: ↓bilateral parahippocampal gyrus, right lateral and left 
medial OFC
Wendt et al. 23 13 SP spider 
13 controls
13-0
13-0
23.2
21.1
Not stated Not stated 1.5 1st fMRI/BOLD (phobia relevant, neutral, pleasant, 
unpleasant and complex neutral pictures) 2nd fMRI 
(pictures) acoustic startle eliciting stimulus. ROI
SP: ↑ amygdala activation, was not fear specific SP: ↑ insula 
activation during sustained SP-exposure
Aupperle et al. 47 12 SP placebo
11 SP DCS
11 controls placebo
12 controls DCS
7-5
10-1
8-3 
8-4
26.00 ±8.06
24.73 ±6.65
23.09 ± 3.70
26.75 ± 9.09
Right-handed Comorbidity: no.
Medication: free
3.0 fMRI/ BOLD (spiders, butterfly, Gaussian-blurred 
pictures) + DCS 100 mg or placebo. ROI
SP: SP-DCS: ↑ prefrontal cortex, dorsal ACC, insular activations 
Controls - DCS: ↑ ventral ACC and caudate activations
Schienle et al. 47 10 SP spider
8 controls
10-0
8-0
29.1 ± 11.5
24 ± 3.7
Right-handed Comorbidity: no.
Medication: free
1.5 Six months CBT follow-up: fMRI (disgust, fear, 
neutral) ROI
SP: SP -relevant: ↓ insula and lateral OFC activation and ↑ 
medial OFC comparing the first session. Controls: ↓ medial OFC 
activity comparing with the first session.
Hermann et al. 39 14 SP spider 14-0 22.1 ± 2.8 Right-handed Comorbidity: no.
Medication: free
1.5 fMRI /BOLD (SP-relevant, aversive and neutral 
pictures) /up- and down-regulate emotions elicited 
by pictures. ROI
SP: up-regulation: ↑ insula, amygdala, dACC ↓ ventromedial 
prefrontal cortex activity , SP: SP-relevant: ↑ insula ↓ DMPFC 
activity SP: down-regulation: ↓ ACC and insula
Alpers et al. 30 19 SP spider 19-0 22.5 Not stated Medication: free 1.5 fMRI (SP-relevant and neutral pictures) + moving 
or stationary animal stimulus - double exposure 
displays
SP: SP-relevant: ↑ amygdala activation (dose–response 
relationship) SP: neutral pictures: did not result in significant 
amygdala activation
Britton et al. 34 12 SP animal
12 controls
7-5
8-4
25.2 ± 4.5
26.7 ± 5.5
Right-handed Comorbidity: no.
Medication: free
3.0 fMRI/ BOLD (SP-related, negative, and neutral 
words) +event-related emotional counting Stroop 
task. ROI
SP: ↑ ACC rostral activation/ positive relationship between 
rACC and left amygdala activation Controls: ↑ right amygdala, 
posterior insula activations and greater thalamic deactivation
Caseras et al. 42 26 SP 14 spider 
12 BII
14 controls
11-3
9-3
11-3
22.71 ± 2.89 
24.58 ± 4.31
23.0 ± 2.66
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/ BOLD (SP: spider BII and  neutral pictures). 
ROI
SP: ↑ dorsal ACC and anterior insula activation in compared 
to BII phobics and healthy controls BII: ↑ thalamus and visual/
attention areas (occipito-temporo-parietal cortex) activation 
compared with the other groups
Caseras et al. 43 29 SP 14 spider
15 BII
17 controls
12-2
13-2
15-2
21.50 ± 2.73
22.40 ± 2.32
21.76 ± 2.8
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/ BOLD (spiders, needles and  neutral) ROI BII x controls: ↑ ventral prefrontal cortex activity. spider SP: 
↓ activity peak in the left amygdale BOLD responses -spider SP 
had quicker time-to-peak in the right amygdala than controls
Lueken et al.41 12 SP snake 
12 SP dental
17 controls
9-3
9-3
12-5
 25.1 ±7.03
25.6 ±7.54
23.7 ± 4.44
40 right handed
1 left handed
Comorbidity: no.
Medication: free
3.0 fMRI/ BOLD (video-based paradigm for symptom 
provocation was used -snake and dental). ROI
Snake Phobics: ↑activation of insula,ACC and thalamus; Dental 
phobics: activation of the prefrontal and OFC when compared 
to snake phobics
Schweckendiek 
et al.26
15 SP spider  
14 HC
13-2
12-2
23.53 ± 3.27
23.64 ± 3.43
Right-handed Comorbidity: no.
Medication: free
1.5 fMRI/BOLD (investigated conditioned responses 
using SP-relevant and non-SP-relevant unconditioned 
picture).ROI
 SP: SP-relevant picture: ↑ medial prefrontal cortex,ACC, 
amygdala, insula and thalamus activation SP: ↑ amygdala 
activation in response to the SP conditioned picture than to the 
non-SP conditioned
↓, decrease; ↑, increase; F, female; M, male; SD, standard deviation; m, mean; SP, specific phobia; BII, blood-injection injury; rACC,rostral anterior cingulate cortex; BOLD, blood oxygen level-dependent;  ACC, 
anterior cingulare cortex, DMPFC, dorsomedial prefrontal cortex; ;  OFC, orbitofrontal cortex; TG, therapy group; WL, wating list; DCS, D-cycloserine; MPFC, medial prefrontal cortex; BNST, bed nucleus of the 
stria terminalis; CBT, Cognitive Behavioral Therapy; ROI, region of intere.
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besides the regulation of emotional responses.60 Studies 
show that lesions in this structure have produced various 
symptoms, including apathy, inattention, dysregulation of 
autonomic functions, and emotional instability. In individuals 
with animal phobia, activation of the ACC has been consis-
tently observed when subjects were shown a phobia-related 
picture.6,24,37
The medial prefrontal cortex (MPFC) is understood as 
having specific roles in risk assessment and cognitive pro-
cessing during defensive reactions.61 Thus, it is likely that 
the abnormal activity in the MPFC might be relevant in 
anxiety disorders, including SP.62 Some studies showed de-
creased responses in areas of the medial prefrontal cortex 
(MPFC)29,36,40,56,63 in people with SP who were shown phobia-
related pictures, which was associated with reduced cogni-
tive control of aversive emotions in these patients.
The increased activation in the anterior insula observed 
in SP studies17,24 is consistent with the role attributed to the 
structure, which may be related to the representation of 
internal bodily states.64 The insular cortex exerts control 
over visceral and autonomic functions via connection to brain 
stem, diencephalon and amygdale.65 In addition, it has an 
important role in the mediation among the sensory input, 
autonomic systems and brain regions involved in higher-order 
processing.22
It is important to emphasize that results related to the 
activation of paralimbic and limbic structures as the amyg-
dala, hippocampus, insula and medial prefrontal cortex are 
not exclusive to SP. Similar observations were confirmed in 
PTSD,66,67 OCD,68,69 social phobia,70 and panic disorder (PD).71 
Together, these results suggest that the increased activity of 
limbic structures is associated with fear and anxiety, which 
are present in SP but are not specific to the disorder. 
The few studies investigating the neural substrate of 
drug treatment in SP were inconclusive or contradictory. 
Traditional drugs such as benzodiazepines have been inves-
tigated, but there was no change in levels of subjective fear 
and physiological studies on patients with SP.14 However, 
after confirming that D-cycloserine (partial agonist of NMDA 
neuronal receptors) caused activation in structures such as 
prefrontal DCS, dorsal ACC, and insula of phobic individuals,44 
it was suggested that this substance might contribute to a 
possible clinical improvement of patients and as a possible 
therapeutic option.
As for the psychotherapeutic treatment of the disorder, 
it is known that behavioral therapy with in vivo exposure 
is currently the most effective method of intervention.72 
Patients are advised to approach the feared stimulus in a 
gradual manner until the anxiety experienced decreases 
substantially. The immediate, positive, and long-term ef-
fects of CBT are documented,73-78 and it was reported that 
benefits from immediate treatment were maintained or even 
improved over a 12 months follow-up period.29
It is relevant to mention the methodological charac-
teristics of the studies described in this review, because 
methodological differences hamper the comparability and 
generalization of the results. For example, most samples 
were small (typically N < 20), composed of young adults with 
low rates of comorbidity, which reinforces the importance 
of assessing the consistency of results found. Similarly, 
methodological limitations of previous studies included the 
absence of control groups, no sample matching procedures 
(prevalence of women), the absence of data on laterality, 
and software and MRI equipment differences (Tables 1-4). 
Although authors claim that these peculiarities do not affect 
the results, the generalization and reproducibility of findings 
may be impaired. 
Conclusion
The different techniques used in neuroimaging studies 
showed consistent results regarding the role of the amygdala, 
insula, cingulate cortex, prefrontal and orbitofrontal corti-
ces, thus, reinforcing the hypothesis that there is a specific 
brain circuit, consisting of cortical and limbic areas, that is 
involved in the disorder due to a dysfunction. Differences in 
the role of certain brain regions in patients with different 
phobia subtypes were found; however, further investigation 
is required. Regarding the treatment of the disorder, psy-
chotherapy (CBT) has proven more efficient, contributing 
positively to the reduction of activation in regions that were 
previously hyperactive. Still, it is of critical importance that 
further studies should be conducted in order to expand and 
consolidate literature findings.
Regarding methodological aspects, continuous ad-
vances have been made in the use of functional imaging 
techniques, with more homogeneous samples, with the 
combination of cognitive and behavioral tests and, more 
recently, pursuing the association of neuroimaging and 
psychotherapeutic treatment. Furthermore, fMRI can raise 
hypotheses regarding functional mechanisms, which, in 
the future, may lead to new insights for the diagnosis and 
treatment of SP.
Yet, despite research advances in this area, only one 
study used SPECT, only two studies have investigated corti-
cal thickness in brains of individuals with SP and no study 
has investigated possible metabolite changes through MRS, 
or structure changes by graph analysis, or volume changes 
through VBM. Therefore, it is of fundamental importance to 
carry out further complementary and longitudinal studies 
with larger and more homogeneous samples, and with the 
use of the same sample in different neuroimaging techniques 
in order to contribute to a better understanding of the un-
derlying pathogenesis of SP.
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